SCHEMBL24239147

SCHEMBL24239147

CC1(C)OB(c2cccc(-c3ccc4c(ccc5c6ccccc6oc45)c3)c2)OC1(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 7/20 0.49
LPL P06858 6/20 0.49
ALOX5 P09917 2/20 0.36
CYP2C19 P33261 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CSF1R P07333 1/20 0.36
PGR P06401 1/20 0.34
CYP1A1 P04798 4/20 0.33
CYP1B1 Q16678 4/20 0.33
IRAK4 Q9NWZ3 1/20 0.33
CYP1A2 P05177 3/20 0.32
KDM4E B2RXH2 1/20 0.32
PDE5A O76074 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TP53 P04637 1/20 0.32
ABCB1 P08183 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22087260 0.91 LIPG (0.49) LIPGLPLCYP2C19KMT2ACSF1R
SCHEMBL22697850 0.91 LIPG (0.61) LIPGLPLALOX5CYP2C19MEN1
SCHEMBL18164752 0.90 LIPG (0.48) LIPGLPLCYP2C19KMT2ACSF1R
SCHEMBL22087264 0.89 LIPG (0.50) LIPGLPLALOX5CYP2C19MEN1
SCHEMBL21146839 0.88 LPL (0.46) LIPGLPLCYP2C19MEN1KMT2A
SCHEMBL24239226 0.88 LIPG (0.49) LIPGLPLALOX5CYP2C19MEN1
SCHEMBL24239150 0.87 ALOX5 (0.44) LIPGLPLALOX5CYP2C19MEN1
SCHEMBL25491756 0.85 LIPG (0.49) LIPGLPLMEN1KMT2ACSF1R
SCHEMBL22087251 0.85 LIPG (0.54) LIPGLPLALOX5CYP2C19MEN1
SCHEMBL24239149 0.84 LIPG (0.42) LIPGLPLALOX5CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11800795-B2 Compound for organic electric element, organic electric element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-10-24 US disclosed
US-11800795-B2 Compound for organic electric element, organic electric element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-10-24 US disclosed
US-20230115134-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-04-13 US disclosed
US-20220037594-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2022-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230115134-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF PIEZO1, ORAI2, OR10J3 LIPG 1322/4885LPL 3264/4885ALOX5 624/4885
US-11800795-B2 Compound for organic electric element, organic electric element using the same, and an electronic device thereof PIEZO1, ORAI2, OCIAD1 LIPG 1225/4885LPL 2953/4885ALOX5 794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.